Uta Reibetanz

Dr. Uta Reibetanz


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2012 in ACS Nano
Verified
Journal Article
Closed access
URUta Reibetanz
Uta Reibetanz
MSMaria Schönberg
Maria Schönberg
SRSophie Rathmann
Sophie Rathmann
VSVincent Strehlow
Vincent Strehlow
MGMartin Göse
Martin Göse
JLJacqueline Leßig
Jacqueline Leßig

22 November 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MSMerle Scherf
Merle Scherf
FSFlorian Scheffler
Florian Scheffler
CMChristopher Maffeo
Christopher Maffeo
UKUlrich Kemper
Ulrich Kemper
JYJingjing Ye
Jingjing Ye
URUta Reibetanz
Uta Reibetanz
DNA nanocages are developed for the encapsulation and delivery of freely diffusing drug cargo molecules. The cargo was attached to the nanotube, and subsequently detached via toehold-mediated strand displacement after tube sealing with lids.

1 January 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
MBMandy Brueckner
Mandy Brueckner
SJSteffen Jankuhn
Steffen Jankuhn
EJEva-Maria Jülke
Eva-Maria Jülke
URUta Reibetanz
Uta Reibetanz
Background: Drug delivery systems (DDS) and their interaction with cells are a controversial topic in the development of therapeutic concepts and approaches. On one hand, DDS are very useful for protected and targeted transport of defined dosages of active agents. On the other hand, their physicochemical properties such as material, size, shape, charge, or stiffness have a huge impact on cellular uptake and intracellular processing. Additionally, even identical DDS can undergo a completely diverse interaction with different cell types. However, quite often in in vitro DDS/cell interaction experiments, those aspects are not considered and DDS and cells are randomly chosen. Methods and results: Hence, our investigations provide an insight into layer-by-layer designed microcarriers with modifications of only some of the most important parameters (surface charge, stiffness, and applied microcarrier/cell ratio) and their influence on cellular uptake and viability. We also considered the interaction of these differently equipped DDS with several cell types and investigated professional phagocytes (neutrophil granulocytes; macrophages) as well as non-professional phagocytes (epithelial cells) under comparable conditions. We found that even small modifications such as layer-by-layer (LbL)-microcarriers with positive or negative surface charge, or LbL-microcarriers with solid core or as hollow capsules but equipped with the same surface properties, show significant differences in interaction and viability, and several cell types react very differently to the offered DDS. Conclusion: As a consequence, the properties of the DDS have to be carefully chosen with respect to the addressed cell type with the aim to efficiently transport a desired agent.

19 July 2018 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
MBMandy Brueckner
Mandy Brueckner
KSKira Scheffler
Kira Scheffler
URUta Reibetanz
Uta Reibetanz
Nano- and microcarriers as vehicles for active agents are additionally equipped with specific agents to prevent endolysosomal acidification in order to support them to reach their target in a defined, specific, and protected way.

8 September 2010 in Advanced Engineering Materials
Verified
Journal Article
Closed access
PDF file
URUta Reibetanz
Uta Reibetanz
JLJaqueline Lessig
Jaqueline Lessig
JHJan Hoyer
Jan Hoyer
Ines NeundorfInes Neundorf
Ines Neundorf

27 August 2022 in European Spine Journal
Verified
Journal Article
Open access
PDF file
HSHanno Steinke
Hanno Steinke
TSToshiyuki Saito
Toshiyuki Saito
JKJanne Kuehner
Janne Kuehner
URUta Reibetanz
Uta Reibetanz
CHChristoph - Eckhard Heyde
Christoph - Eckhard Heyde
AVAnna Voelker
Anna Voelker
Purpose: To investigate the innervation pattern of the sacroiliac region, especially with regard to the sacroiliac joint (SIJ). Dorsal SIJ innervation was analyzed and described. Our main hypothesis was that nerves reach the SIJ dorsally, passing ligamental compartments, as this would explain dorsal SIJ pain. Methods: To examine sacroiliac innervation, we followed the nerves in over 50 specimens over several years. Plastinated slices were evaluated, nerves in the region were stained histologically, and the data were summarized as 3D models. Results: The Rami communicans and posterior branches of the spinal nerves and their branches that form a dorsal sacral plexus and communicating branches, together with corresponding vessels, were observed to form neurovascular bundles embedded by tiny fatty connectives in gaps and tunnels. Branches of L5-S1 pass the inner sacroiliac ligaments (the interosseous sacroiliac ligament and axial interosseous ligament). The outer sacroiliac ligaments (posterior sacroiliac ligaments, long posterior sacroiliac ligament, sacrotuberal ligament, thoracolumbar fascia) are passed by the S1-S4 branches. However, although the paths of these nerves are in the direction of the SIJ, they do not reach it. It is possible that impingement of the neurovascular bundles may result in pain. Moreover, the gaps and tunnels connect to the open dorsal SIJ. Conclusion: Our findings suggest that Bogduk’s term “sacroiliac pain” correlates to “sacroiliac innervation”, which consists of “inner-” and “outer sacroiliac ligament innervation”, and to ventral “SIJ pain”. The watery gaps and tunnels observed could play a significant role in innervation and thus in the origins of SIJ pain. Level of evidence: Individual cross-sectional studies with consistently applied reference standard and blinding.